East Yorkshire patients are facing a growing crisis as drug shortages continue to impact their access to essential medications. One patient, Meredith, shared her distressing experience, highlighting the challenges of finding her required medication, Levothyroxine. She described the frustration, stress, and time-consuming efforts involved in searching for her medication, emphasizing the difficulty of finding even a partial supply.
The issue of drug shortages is not isolated to East Yorkshire. Globally, medications for ADHD, cancer treatments, statins, opioid painkillers, anesthetics, and antibiotics have experienced persistent or recurring shortages. In the UK, a total of 124 drugs are currently in short supply, according to a MIMS tracker, down from 142 in February 2025. This situation has raised concerns and prompted calls for action.
The National Pharmacy Association (NPA) reported that 86% of surveyed pharmacies were unable to supply aspirin to patients in January. This alarming statistic underscores the extent of the problem. The NPA urged the government to expedite plans to eliminate a law that hinders pharmacists from making substitutions when faced with low stock. The government, in response, has committed to investing up to £520 million to enhance domestic medicine manufacturing, diagnostics, and medical technologies, as well as streamlining the life sciences sector and strengthening supply chains. These efforts aim to address the underlying causes of drug shortages and ensure a more reliable supply of essential medications for patients across the country.
